1don MSN
AI-designed diffractive optical processors pave the way for low-power structural health monitoring
A team of researchers at the University of California, Los Angeles (UCLA) has introduced a novel framework for monitoring ...
UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results